Ocular Therapeutix™ to Participate in September and October Investor and Scientific Conferences
Ocular Therapeutix announced it will participate in the Wells Fargo 21st Annual Healthcare Conference and the Baird 2026 Global Healthcare Conference, where CEO Pravin Dugel will host a fireside chat. At upcoming scientific meetings including the Retina Society Annual Meeting and Euretina Congress, the company and investigators will present Phase 3 SOL-1 trial results for OTX-TKI in neovascular age-related macular degeneration.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.